Table 1

Extracted data items—meta-data, MRI technique, reference test and patient characteristics

Data item(s)LevelsExplanation
Meta-data of study*Journal/year
/volume/authors
Study type*Prospective or retrospective observational or interventional
MRI technique, index test
VendorManufacturer, magnet product type
Field strength*3 Tesla, 1.5 Tesla, other
Sequence parameters T2wSequence type, slice thickness, gap, planes obtained
Sequence parameters DWISequence type, slice thickness, gap, b-values used
Sequence parameters DCESequence type, slice thickness, gap, temporal resolution
Endorectal coil usedCategorical
Spasmolytic agent usedCategorical
Number of radiologists involvedNumerical
Experience of radiologists involvedNumerical (in years)Most experienced radiologist considered for diagnostic accuracy estimation
Reference test
Target lesion biopsy technique*Cognitive ultrasound fusion, MRI US fusion transrectal, MRI US fusion transperineal, in-boreAdditionally: mean/median number of biopsy cores per lesion
Systematic biopsy technique*Not performed, standard 8–12 cores, extended systematic biopsy (eg, Ginsburg scheme), template biopsy, prostatectomy specimen usedAdditionally: mean/median number of systematic biopsy cores taken per patient
MRI-directed perilesional biopsiesCategoricalIf available, mean/median number of perilesional biopsies per lesion is recorded
Patient characteristics
Number of patients and/or number of lesions*NumericalIf information for lesion localisation (peripheral zone and transition zone) is reported separately, this information is recorded
Mean/median age*Numerical
Mean/median PSA*Numerical
Mean/median prostate volumeNumerical

  • *Core data items—if missing, authors of the primary studies are contacted two times to obtain the missing data.

  • DCE, dynamic contrast enhanced; DWI, diffusion-weighted imaging; PSA, prostate specific antigen; T2w, T2-weighted; US, ultrasound.